goat anti egfr Search Results


polyclonal goat antibodies  (ProSci Incorporated)
90
ProSci Incorporated polyclonal goat antibodies
Escherichia coli–produced recombinant VP40 and Ebola virus (EBOV) virus-like particles (VLPs) precipitated from supernatants of HEK-293T/17 cell cultures transfected with EBOV VP40, EBOV nucleoprotein (NP), and EBOV glycoprotein (GP) mammalian expression constructs were resolved on nonreducing Bis-Tris/MES sodium dodecyl sulfate polyacrylamide gels. Proteins were transferred to nitrocellulose membranes and probed with goat anti-VP40 or goat anti-NP <t>polyclonal</t> antibodies (VHFC) and a rabbit anti-goat immunoglobulin G (H + L)-HRP (KPL). Blots were imaged with LumiGlo chemiluminescent substrate (KPL) in a GE ImageQuant LAS4000 imager.
Polyclonal Goat Antibodies, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+egfr/pmc04564556-87-1-7?v=ProSci+Incorporated
Average 90 stars, based on 1 article reviews
polyclonal goat antibodies - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
goat polyclonal antibody  (Cusabio)
92
Cusabio goat polyclonal antibody
Escherichia coli–produced recombinant VP40 and Ebola virus (EBOV) virus-like particles (VLPs) precipitated from supernatants of HEK-293T/17 cell cultures transfected with EBOV VP40, EBOV nucleoprotein (NP), and EBOV glycoprotein (GP) mammalian expression constructs were resolved on nonreducing Bis-Tris/MES sodium dodecyl sulfate polyacrylamide gels. Proteins were transferred to nitrocellulose membranes and probed with goat anti-VP40 or goat anti-NP <t>polyclonal</t> antibodies (VHFC) and a rabbit anti-goat immunoglobulin G (H + L)-HRP (KPL). Blots were imaged with LumiGlo chemiluminescent substrate (KPL) in a GE ImageQuant LAS4000 imager.
Goat Polyclonal Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+egfr/pm37914215-56-15-25?v=Cusabio
Average 92 stars, based on 1 article reviews
goat polyclonal antibody - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
goat anti egfr antibody  (Abcepta)
N/A
   Buy from Supplier
goat anti- egfr polyclonal antibody  (Cusabio)
N/A
Goat anti-Human EGFR Polyclonal Antibody
   Buy from Supplier
goat anti-egfr antibody  (Angio-Proteomie)
N/A
   Buy from Supplier
goat anti-egfr  (everest biotech)
N/A
This antibody is expected to recognise isoform a (NP_005219.2) only.
   Buy from Supplier

Image Search Results


Escherichia coli–produced recombinant VP40 and Ebola virus (EBOV) virus-like particles (VLPs) precipitated from supernatants of HEK-293T/17 cell cultures transfected with EBOV VP40, EBOV nucleoprotein (NP), and EBOV glycoprotein (GP) mammalian expression constructs were resolved on nonreducing Bis-Tris/MES sodium dodecyl sulfate polyacrylamide gels. Proteins were transferred to nitrocellulose membranes and probed with goat anti-VP40 or goat anti-NP polyclonal antibodies (VHFC) and a rabbit anti-goat immunoglobulin G (H + L)-HRP (KPL). Blots were imaged with LumiGlo chemiluminescent substrate (KPL) in a GE ImageQuant LAS4000 imager.

Journal: The Journal of Infectious Diseases

Article Title: Development of Prototype Filovirus Recombinant Antigen Immunoassays

doi: 10.1093/infdis/jiv353

Figure Lengend Snippet: Escherichia coli–produced recombinant VP40 and Ebola virus (EBOV) virus-like particles (VLPs) precipitated from supernatants of HEK-293T/17 cell cultures transfected with EBOV VP40, EBOV nucleoprotein (NP), and EBOV glycoprotein (GP) mammalian expression constructs were resolved on nonreducing Bis-Tris/MES sodium dodecyl sulfate polyacrylamide gels. Proteins were transferred to nitrocellulose membranes and probed with goat anti-VP40 or goat anti-NP polyclonal antibodies (VHFC) and a rabbit anti-goat immunoglobulin G (H + L)-HRP (KPL). Blots were imaged with LumiGlo chemiluminescent substrate (KPL) in a GE ImageQuant LAS4000 imager.

Article Snippet: Filovirus-specific polyclonal goat antibodies were generated at ProSci (Poway, California) with purified antigens, using a 13-week immunization and blood specimen collection protocol, with monthly extensions.

Techniques: Produced, Recombinant, Virus, Transfection, Expressing, Construct

Detection of Ebola virus (EBOV)–specific immunoglobulin G (IgG) from patients with suspected Lassa fever presenting to the Kenema Government Hospital Lassa fever ward between 9 April 9 2014 (G3642) and 4 June 2014 (G3718). Microplates were coated with either EBOV VP40 or glycoprotein (GP) or with a combination of both antigens and then were overlaid with serial dilutions of serum from patients with suspected Lassa fever. Polyclonal anti-human IgG–horseradish peroxidase was used as a detection reagent. Blood specimens obtained sequentially from most patients during hospitalization permitted analysis of seroconversion and increasing IgG titers to EBOV antigens. A single blood specimen was available from patient G3642. Sera were analyzed over a titration range, as permitted by available sample volumes. Patient G3670, who survived Ebola, showed a clear rise in titer between the first and second blood specimen collected, although precise end point titers could not be determined because the samples were too small for analysis. Patients G3710 and G3718, who also survived EBOV infection, registered a moderate increase in IgG titers to both EBOV antigens. Patient G3717, who died from Ebola, registered a substantial titer in the first blood specimen, which did not increase significantly over time. Patient G3713, who also died, did not register a significant titer to EBOV antigens throughout the interval during which samples were collected. IgG reactivity to VP40 (blue), GP (red), and the combination of both antigens (green) from duplicate sample analysis is plotted with standard deviations.

Journal: The Journal of Infectious Diseases

Article Title: Development of Prototype Filovirus Recombinant Antigen Immunoassays

doi: 10.1093/infdis/jiv353

Figure Lengend Snippet: Detection of Ebola virus (EBOV)–specific immunoglobulin G (IgG) from patients with suspected Lassa fever presenting to the Kenema Government Hospital Lassa fever ward between 9 April 9 2014 (G3642) and 4 June 2014 (G3718). Microplates were coated with either EBOV VP40 or glycoprotein (GP) or with a combination of both antigens and then were overlaid with serial dilutions of serum from patients with suspected Lassa fever. Polyclonal anti-human IgG–horseradish peroxidase was used as a detection reagent. Blood specimens obtained sequentially from most patients during hospitalization permitted analysis of seroconversion and increasing IgG titers to EBOV antigens. A single blood specimen was available from patient G3642. Sera were analyzed over a titration range, as permitted by available sample volumes. Patient G3670, who survived Ebola, showed a clear rise in titer between the first and second blood specimen collected, although precise end point titers could not be determined because the samples were too small for analysis. Patients G3710 and G3718, who also survived EBOV infection, registered a moderate increase in IgG titers to both EBOV antigens. Patient G3717, who died from Ebola, registered a substantial titer in the first blood specimen, which did not increase significantly over time. Patient G3713, who also died, did not register a significant titer to EBOV antigens throughout the interval during which samples were collected. IgG reactivity to VP40 (blue), GP (red), and the combination of both antigens (green) from duplicate sample analysis is plotted with standard deviations.

Article Snippet: Filovirus-specific polyclonal goat antibodies were generated at ProSci (Poway, California) with purified antigens, using a 13-week immunization and blood specimen collection protocol, with monthly extensions.

Techniques: Virus, Titration, Infection